BRONXCARE HEALTH SYSTEM
1. Target Overview & Investment Thesis
BRONXCARE HEALTH SYSTEM is a 454-bed suburban community hospital in BRONX, NY with $870.4M in net patient revenue and a 3.0% operating margin. The hospital serves a payer mix of 9.3% Medicare, 11.7% Medicaid, and 79.0% commercial.
Thesis: Undervalued. Our ML models identify $64.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.0% to 10.4% (+736bps).
| Net Revenue HCRIS | $870.4M |
| Current EBITDA COMPUTED | $26.5M |
| Operating Margin COMPUTED | 3.0% |
| Occupancy HCRIS | 83.1% |
| Revenue / Bed COMPUTED | $1.9M |
| Net-to-Gross HCRIS | 61.2% |
| Distress Probability ML | 45.2% |
2. Market Context & Competitive Position
NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of 3.0% places it above the state median. Among 62 size-comparable peers (227-908 beds), the median margin is -17.7%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (227-908), prioritizing same-state peers. 62 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BRONXCARE HEALTH SYSTEM (Target) | NY | 454 | $870.4M | 3.0% |
| MEMORIAL HOSPITAL FOR CANCER A | NY | 514 | $4.34B | -32.5% |
| STRONG MEMORIAL HOSPITAL | NY | 749 | $3.31B | 5.2% |
| NORTH SHORE UNIVERSITY HOSPITA | NY | 782 | $2.27B | -50.0% |
| STONY BROOK UNIVERSITY HOSPITA | NY | 725 | $1.90B | -4.9% |
| WESTCHESTER MEDICAL CENTER | NY | 696 | $1.63B | 2.6% |
| UNIVERSITY HOSPITAL AT SYRACUS | NY | 625 | $1.33B | -17.2% |
| LENOX HILL HOSPITAL | NY | 415 | $1.32B | -35.1% |
| BELLEVUE HOSPITAL CENTER | NY | 527 | $1.31B | -17.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $64.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $18.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $17.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $17.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $10.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $557K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $26.5M |
| + RCM Uplift | +$64.1M |
| Pro Forma EBITDA | $90.5M |
| Current Margin | 3.0% |
| Pro Forma Margin | 10.4% |
| WC Released (1x) | $33.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $40.7M | $815.1M | 20.03x | 82.1% |
| Base (11x exit) | 10.0x | 11.0x | $40.7M | $909.9M | 22.36x | 86.2% |
| Bull Case | 9.0x | 11.0x | $36.6M | $1.13B | 30.97x | 98.7% |
| Bull (12x exit) | 9.0x | 12.0x | $36.6M | $1.25B | 34.08x | 102.5% |
| Bear Case | 11.0x | 10.0x | $44.8M | $481.6M | 10.76x | 60.8% |
| Bear (11x exit) | 11.0x | 11.0x | $44.8M | $544.3M | 12.16x | 64.8% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 62 hospitals with 227-908 beds
- Same-state prioritization (n=63)
- Comp margins: P25=-26.5% / P50=-17.7% / P75=-9.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.